Results for tag: "Nuplazid"

Nuplazid is a drug used to treat hallucinations and delusions associated with Parkinson's disease psychosis. It is the only FDA-approved medication specifically indicated for this condition. Nuplazid works by blocking the action of serotonin, a neurotransmitter that is involved in the regulation of mood and behavior. It is available in tablet form and is taken orally. Nuplazid is part of a larger market of drugs used to treat schizophrenia. These drugs are typically divided into two categories: antipsychotics and mood stabilizers. Antipsychotics are used to reduce the symptoms of psychosis, such as hallucinations and delusions, while mood stabilizers are used to reduce the intensity of mood swings. Other drugs used to treat schizophrenia include antidepressants, anxiolytics, and antipsychotic-antidepressant combinations. The companies in the Nuplazid market include Acadia Pharmaceuticals, Otsuka Pharmaceuticals, and Sunovion Pharmaceuticals. Show Less Read more